Table 2 Participants’ chronic medical conditions (N = 192)

median (IQR)

6 (5–7)

Number of chronic medical conditions^a

n (%)

 ≤ 3 medical conditions

16 (8.3)

 4 to 5 medical conditions

58 (30.2)

 6 to 7 medical conditions

74 (38.5)

 ≥ 8 medical conditions

44 (22.9)

Chronic medical conditions

n (%)

 Myocardial infarction (history of)

13 (6.8)

 Coronary disease/angina

25 (13)

 Congestive heart failure

17 (8.9)

 Hypertension

164 (85.4)

 Dyslipidemia

147 (76.6)

 Peripheral vascular disease

63 (32.8)

 Cerebrovascular disease

14 (7.3)

 Hemiplegia or paraplegia

9 (4.7)

 Other neurologic disease ^b

11 (5.7)

 Chronic pulmonary disease

18 (9.4)

 Diabetes without end-organ damage

47 (24.5)

 Diabetes with end organ

7 (3.6)

 Chronic renal disease (moderate to severe)

3 (1.6)

 Mild liver disease

8 (4.2)

 Moderate to severe liver disease

1(0.5)

 Gastric disease (any history of ulcer disease treatment or prevention, ulcer bleeding, or GERD)

78 (40.6)

 Prostate disease (benign hypertrophy, neoplasia)

30 (15.6)

 Neoplasia (solid tumor other than prostate)

29 (15.1)

 Metastatic solid tumor

2 (1.04)

 Lymphoma

4 (2.1)

 Arthrosis, spinal disorders, or rheumatoid arthritis

188 (97.9)

 Chronic pain

68 (35.4)

 Osteoporosis

31 (16.1)

 Overweight or obesity

72 (37.5)

 Depression

67 (34.9)

 Anxiety, panic disorder

82 (42.7)

 Other

4 (2.1)

Age-adjusted Charlson Comorbidity Index^c (N = 192)

Median (IQR)

9 (8–11)